Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Microfluidics chips for simplifying medical imaging biomarkers of disease

A collaboration between scientists at UCLA, Caltech, Stanford, Siemens and Fluidigm have developed a new technology using integrated microfluidics chips for simplifying, lowering the cost and diversifying the types of molecules used to image the biology of disease with the medical imaging technology, Positron Emission Tomography (PET).

15 Dec 2005

Mesoblast recruits first patients for pilot clinical trials

Australia's adult stem cell company, Mesoblast Limited, today announced that several patients have now been formally recruited for its Pilot Clinical Trials.

6 Dec 2005

Who gets bird flu vaccine first when there's not enough to go round?

According to the top health official in the U.S., it will be three to five years before the United States can produce enough bird flu vaccine to inoculate its population against a potentially deadly outbreak in humans.

21 Nov 2005

Human bird flu cases confirmed in China

According to official sources in China, at least one person has died from bird flu, confirming widespread suspicion that the deadly virus has now spread in people in another large Asian country where it might prove hard to contain.

16 Nov 2005

Important that GP's take flu pandemic threat seriously

Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.

7 Nov 2005

New high-resolution data on intact ribosome

A new, sharper picture of the nano-machine that translates our genetic program into proteins promises to help researchers explain how some types of antibiotics work and could lead to the design of better ones.

7 Nov 2005

New technique provides supplies of seed viruses to fight bird flu

Researchers in the U.S. believe that a new manufacturing method may allow large quantities of vaccine to quickly be deployed against a deadly bird flu pandemic.

1 Nov 2005

$107.6 million grant for malaria vaccine candidate

In an important step toward developing an effective malaria vaccine, the Bill & Melinda Gates Foundation has announced a $107.6 million grant to the PATH Malaria Vaccine Initiative (MVI) to extend the public-private partnership between MVI and GlaxoSmithKline Biologicals (GSK Bio) to develop GSK Bio's malaria vaccine for children in Africa.

30 Oct 2005

Chiron initiates Phase I/II study of an investigational cell culture-derived influenza vaccine

Cell culture-derived influenza vaccine (commonly referred to as "flu cell culture" vaccine) represents the next generation of influenza vaccine, both for annual vaccine production and for long-term pandemic preparedness.

26 Oct 2005

New strategies to help developing countries address neglected diseases

For the health challenges facing developing countries, the numbers alone are staggering. Every day, 40,000 people - enough to fill a sports stadium - die from preventable infectious diseases and malnutrition. Entire generations of human potential are perishing.

25 Oct 2005

FDA approves first transplant of fetal stem cells into human brains

The U.S. Food and Drug Administration has approved the first transplant of fetal stem cells into human brains, a procedure that if successful could pave the way to treating a host of neural disorders.

24 Oct 2005

A DNA-based vaccine could be a potent weapon against bird flu

Researchers scrambling to combat a virulent form of bird flu that could mutate into a form easily spread among humans should consider developing vaccines based on DNA, according to British biochemical engineers.

19 Oct 2005

Patents no problem say Roche when it comes to speeding up production of Tamiflu

High profile Swiss drug maker Roche says it will not let patents stand in the way of getting its Tamiflu drug to patients in the event of a bird flu pandemic.

19 Oct 2005

Discovery establishes a role for the gene Rsf-1 in ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. The scientists say the discovery is the first to establish a role for the gene in ovarian cancer and may lead to a test that can predict, early on, which patients will develop aggressive disease.

3 Oct 2005

Wound dressing to stop antibiotic-resistant bacteria from spreading

University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.

27 Sep 2005

Downward mobility hits men far harder than women

The findings are based on survey responses from 503 men and women taking part in the Newcastle Thousand Families Study, all of whom were born in May and June 1947 to mothers living in Newcastle upon Tyne, north east England.

26 Sep 2005

Shot in the arm for vaccines

A Flinders University research program to develop new forms of vaccine against infectious diseases has received over $3 million in funding from the United States Government's National Institutes of Health.

6 Sep 2005

GlaxoSmithKline acquires vaccine R&D and manufacturing plant in the U.S.

GlaxoSmithKline has announced that it is expanding its ability to increase vaccines supplies for Americans by acquiring a vaccine research and production facility in Marietta, Pennsylvania.

1 Sep 2005

New vaccine approved for U.S. just in time for flu season

A new flu vaccine has been approved by U.S. health officials in an attempt to bolster up supplies after last season's shortage.

31 Aug 2005

Emergent Biosolutions' typhoid vaccine achieves positive results in Phase II clinical study

Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.

30 Aug 2005